Getting Biopharmaceutical Tech Transfer Right the First Time

Good project management, budgeting, planning, and clear documentation are the only ways to prevent overruns and project failure.

Biopharmaceutical experts Stephen Perry, CEO of Kymanox, James Blackwell, principal consultant with The Windshire Group, and consultant Mike Ultee, share best practices and musts to avoid in biopharmaceutical technology transfer. Some crucial takeaways? Share all data (especially data on failed runs in the past), and include clear instructions for sampling. In addition, aim for reproducibility.

Download BioPharm International's

2017 Outsourcing Resources eBook

.

Articles in this issue

over 8 years ago

Article

Customer Relationship Management in Contract Manufacturing

over 8 years ago

Article

Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies

over 8 years ago

Article

CMOs Tackle New Challenges

over 8 years ago

Article

Gearing Up for Biosimilars

over 8 years ago

Article

Insourcing vs Outsourcing: Choosing the Right Strategy

over 8 years ago

Article

Operations and Quality Oversight of CMOs

over 8 years ago

Article

Quality Metrics and CMO Agreement

over 8 years ago

Article

Key Considerations in Outsourced “On-Site” Audits as Part of Supplier Qualification

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!